Will antimicrobial resistance of BRD pathogens impact BRD management in the future?
Resistance is a qualitative interpretation of antimicrobial activity in vitro. Critical to management of bovine respiratory disease (BRD) is the clinical response in vivo. Attempts to connect activity in vitro to response in vivo have been complicated by the complexity of BRD, interpretation of anti...
Gespeichert in:
| Veröffentlicht in: | Animal health research reviews 2014-12, Vol.15 (2), p.175-177 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 177 |
|---|---|
| container_issue | 2 |
| container_start_page | 175 |
| container_title | Animal health research reviews |
| container_volume | 15 |
| creator | Brumbaugh, Gordon W. |
| description | Resistance is a qualitative interpretation of antimicrobial activity in vitro. Critical to management of bovine respiratory disease (BRD) is the clinical response in vivo. Attempts to connect activity in vitro to response in vivo have been complicated by the complexity of BRD, interpretation of antimicrobial activity in vitro, and inconsistent measures of clinical success or failure. During recent history, the discovery, development, and commercialization of antimicrobials have decreased. In response to resistance, voluntary and imposed restrictions on use of antimicrobials have been implemented. Resistance can be reversed using technology and knowledge of mechanisms of resistance. Perhaps approaches that reverse resistance will be used in clinical management of BRD in the future. The short answer to the question posed in the title is, ‘yes.’ Since antimicrobial drugs were discovered, resistance has been a consideration for selection of treatment of any infectious disease and BRD is not unique. In the opinion of the author, the more important question is, ‘How will antimicrobial resistance of BRD pathogens impact BRD management in the future?’ |
| doi_str_mv | 10.1017/S1466252314000279 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1694974978</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S1466252314000279</cupid><sourcerecordid>1637571048</sourcerecordid><originalsourceid>FETCH-LOGICAL-c476t-9002976aeec1f4e0e0be6ed9396de07bc465b96f383537127d090f7ea6aa1d0f3</originalsourceid><addsrcrecordid>eNqNkUtLAzEUhYMotlZ_gBsJuHEzmtckzUp8KxQEq7gcMjN32pR51CSz8N-bahVRBCGQkPudc3NzENqn5JgSqk6mVEjJUsapIIQwpTfQkAqVJkymYnN1ljJZ1Qdox_sFiRo2FttowFJBCZNsiKbPtq6xaYNtbOG63JoaO_DWB9MWgLsKnz9c4qUJ824Grce2WZoivF82pjUzaKAN2LY4zAFXfegdnO6ircrUHvbW-wg9XV89Xtwmk_ubu4uzSVIIJUOi45O1kgagoJUAAiQHCaXmWpZAVF4ImeZaVnzMU64oUyXRpFJgpDG0JBUfoaMP36XrXnrwIWusL6CuTQtd7zMqtdAqrvE_UK5SRYlYoYc_0EXXuzYOEikxpjzVkR4h-kHFT_PeQZUtnW2Me80oyVbhZL_CiZqDtXOfN1B-KT7TiABfm5omd7acwbfef9q-AQ4VltY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1648135916</pqid></control><display><type>article</type><title>Will antimicrobial resistance of BRD pathogens impact BRD management in the future?</title><source>MEDLINE</source><source>Cambridge University Press Journals Complete</source><creator>Brumbaugh, Gordon W.</creator><creatorcontrib>Brumbaugh, Gordon W.</creatorcontrib><description>Resistance is a qualitative interpretation of antimicrobial activity in vitro. Critical to management of bovine respiratory disease (BRD) is the clinical response in vivo. Attempts to connect activity in vitro to response in vivo have been complicated by the complexity of BRD, interpretation of antimicrobial activity in vitro, and inconsistent measures of clinical success or failure. During recent history, the discovery, development, and commercialization of antimicrobials have decreased. In response to resistance, voluntary and imposed restrictions on use of antimicrobials have been implemented. Resistance can be reversed using technology and knowledge of mechanisms of resistance. Perhaps approaches that reverse resistance will be used in clinical management of BRD in the future. The short answer to the question posed in the title is, ‘yes.’ Since antimicrobial drugs were discovered, resistance has been a consideration for selection of treatment of any infectious disease and BRD is not unique. In the opinion of the author, the more important question is, ‘How will antimicrobial resistance of BRD pathogens impact BRD management in the future?’</description><identifier>ISSN: 1466-2523</identifier><identifier>EISSN: 1475-2654</identifier><identifier>DOI: 10.1017/S1466252314000279</identifier><identifier>PMID: 25410262</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Animals ; Anti-Bacterial Agents - therapeutic use ; Antimicrobial agents ; Bovine Respiratory Disease Complex - drug therapy ; Bovine Respiratory Disease Complex - microbiology ; Cattle ; Disease Management ; Drug Resistance, Microbial ; Infectious diseases ; Microbial Sensitivity Tests ; Pathogens ; Respiratory diseases</subject><ispartof>Animal health research reviews, 2014-12, Vol.15 (2), p.175-177</ispartof><rights>Copyright © Cambridge University Press 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c476t-9002976aeec1f4e0e0be6ed9396de07bc465b96f383537127d090f7ea6aa1d0f3</citedby><cites>FETCH-LOGICAL-c476t-9002976aeec1f4e0e0be6ed9396de07bc465b96f383537127d090f7ea6aa1d0f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S1466252314000279/type/journal_article$$EHTML$$P50$$Gcambridge$$H</linktohtml><link.rule.ids>164,314,780,784,27924,27925,55628</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25410262$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brumbaugh, Gordon W.</creatorcontrib><title>Will antimicrobial resistance of BRD pathogens impact BRD management in the future?</title><title>Animal health research reviews</title><addtitle>Anim. Health. Res. Rev</addtitle><description>Resistance is a qualitative interpretation of antimicrobial activity in vitro. Critical to management of bovine respiratory disease (BRD) is the clinical response in vivo. Attempts to connect activity in vitro to response in vivo have been complicated by the complexity of BRD, interpretation of antimicrobial activity in vitro, and inconsistent measures of clinical success or failure. During recent history, the discovery, development, and commercialization of antimicrobials have decreased. In response to resistance, voluntary and imposed restrictions on use of antimicrobials have been implemented. Resistance can be reversed using technology and knowledge of mechanisms of resistance. Perhaps approaches that reverse resistance will be used in clinical management of BRD in the future. The short answer to the question posed in the title is, ‘yes.’ Since antimicrobial drugs were discovered, resistance has been a consideration for selection of treatment of any infectious disease and BRD is not unique. In the opinion of the author, the more important question is, ‘How will antimicrobial resistance of BRD pathogens impact BRD management in the future?’</description><subject>Animals</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antimicrobial agents</subject><subject>Bovine Respiratory Disease Complex - drug therapy</subject><subject>Bovine Respiratory Disease Complex - microbiology</subject><subject>Cattle</subject><subject>Disease Management</subject><subject>Drug Resistance, Microbial</subject><subject>Infectious diseases</subject><subject>Microbial Sensitivity Tests</subject><subject>Pathogens</subject><subject>Respiratory diseases</subject><issn>1466-2523</issn><issn>1475-2654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkUtLAzEUhYMotlZ_gBsJuHEzmtckzUp8KxQEq7gcMjN32pR51CSz8N-bahVRBCGQkPudc3NzENqn5JgSqk6mVEjJUsapIIQwpTfQkAqVJkymYnN1ljJZ1Qdox_sFiRo2FttowFJBCZNsiKbPtq6xaYNtbOG63JoaO_DWB9MWgLsKnz9c4qUJ824Grce2WZoivF82pjUzaKAN2LY4zAFXfegdnO6ircrUHvbW-wg9XV89Xtwmk_ubu4uzSVIIJUOi45O1kgagoJUAAiQHCaXmWpZAVF4ImeZaVnzMU64oUyXRpFJgpDG0JBUfoaMP36XrXnrwIWusL6CuTQtd7zMqtdAqrvE_UK5SRYlYoYc_0EXXuzYOEikxpjzVkR4h-kHFT_PeQZUtnW2Me80oyVbhZL_CiZqDtXOfN1B-KT7TiABfm5omd7acwbfef9q-AQ4VltY</recordid><startdate>20141201</startdate><enddate>20141201</enddate><creator>Brumbaugh, Gordon W.</creator><general>Cambridge University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20141201</creationdate><title>Will antimicrobial resistance of BRD pathogens impact BRD management in the future?</title><author>Brumbaugh, Gordon W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c476t-9002976aeec1f4e0e0be6ed9396de07bc465b96f383537127d090f7ea6aa1d0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antimicrobial agents</topic><topic>Bovine Respiratory Disease Complex - drug therapy</topic><topic>Bovine Respiratory Disease Complex - microbiology</topic><topic>Cattle</topic><topic>Disease Management</topic><topic>Drug Resistance, Microbial</topic><topic>Infectious diseases</topic><topic>Microbial Sensitivity Tests</topic><topic>Pathogens</topic><topic>Respiratory diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brumbaugh, Gordon W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Animal health research reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brumbaugh, Gordon W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Will antimicrobial resistance of BRD pathogens impact BRD management in the future?</atitle><jtitle>Animal health research reviews</jtitle><addtitle>Anim. Health. Res. Rev</addtitle><date>2014-12-01</date><risdate>2014</risdate><volume>15</volume><issue>2</issue><spage>175</spage><epage>177</epage><pages>175-177</pages><issn>1466-2523</issn><eissn>1475-2654</eissn><abstract>Resistance is a qualitative interpretation of antimicrobial activity in vitro. Critical to management of bovine respiratory disease (BRD) is the clinical response in vivo. Attempts to connect activity in vitro to response in vivo have been complicated by the complexity of BRD, interpretation of antimicrobial activity in vitro, and inconsistent measures of clinical success or failure. During recent history, the discovery, development, and commercialization of antimicrobials have decreased. In response to resistance, voluntary and imposed restrictions on use of antimicrobials have been implemented. Resistance can be reversed using technology and knowledge of mechanisms of resistance. Perhaps approaches that reverse resistance will be used in clinical management of BRD in the future. The short answer to the question posed in the title is, ‘yes.’ Since antimicrobial drugs were discovered, resistance has been a consideration for selection of treatment of any infectious disease and BRD is not unique. In the opinion of the author, the more important question is, ‘How will antimicrobial resistance of BRD pathogens impact BRD management in the future?’</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><pmid>25410262</pmid><doi>10.1017/S1466252314000279</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1466-2523 |
| ispartof | Animal health research reviews, 2014-12, Vol.15 (2), p.175-177 |
| issn | 1466-2523 1475-2654 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1694974978 |
| source | MEDLINE; Cambridge University Press Journals Complete |
| subjects | Animals Anti-Bacterial Agents - therapeutic use Antimicrobial agents Bovine Respiratory Disease Complex - drug therapy Bovine Respiratory Disease Complex - microbiology Cattle Disease Management Drug Resistance, Microbial Infectious diseases Microbial Sensitivity Tests Pathogens Respiratory diseases |
| title | Will antimicrobial resistance of BRD pathogens impact BRD management in the future? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T04%3A34%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Will%20antimicrobial%20resistance%20of%20BRD%20pathogens%20impact%20BRD%20management%20in%20the%20future?&rft.jtitle=Animal%20health%20research%20reviews&rft.au=Brumbaugh,%20Gordon%20W.&rft.date=2014-12-01&rft.volume=15&rft.issue=2&rft.spage=175&rft.epage=177&rft.pages=175-177&rft.issn=1466-2523&rft.eissn=1475-2654&rft_id=info:doi/10.1017/S1466252314000279&rft_dat=%3Cproquest_cross%3E1637571048%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1648135916&rft_id=info:pmid/25410262&rft_cupid=10_1017_S1466252314000279&rfr_iscdi=true |